Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The American Association for Cancer Research (AACR) Annual Meeting 2026 serves as a central gathering for the global cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the latest breakthroughs in cancer science and medicine. Covering a broad spectrum of topics, from population science and prevention to cancer biology, translational and clinical research, survivorship, and advocacy, the 2026 Meeting in San Diego, CA showcased cutting-edge discoveries from leading researchers worldwide.

AACR 2026

17–22 April 2026 | San Diego, CA

AACR 2026

17–22 April 2026 | San Diego, CA
The American Association for Cancer Research (AACR) Annual Meeting 2026 serves as a central gathering for the global cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the latest breakthroughs in cancer science and medicine. Covering a broad spectrum of topics, from population science and prevention to cancer biology, translational and clinical research, survivorship, and advocacy, the 2026 Meeting in San Diego, CA showcased cutting-edge discoveries from leading researchers worldwide.
Molecular subtypes of HPV-associated head and neck cancer and prognosis 2:00
Molecular subtypes of HPV-associated head and neck cancer and prognosis
Wendell Yarbrough • 27 Apr 2026
Circulating HPV DNA in surveillance & MRD-guided head & neck cancer care 3:46
Circulating HPV DNA in surveillance & MRD-guided head & neck cancer care
Wendell Yarbrough • 27 Apr 2026
What does the future hold for cancer vaccines in the solid tumor space? 1:34
What does the future hold for cancer vaccines in the solid tumor space?
Allison Betof Warner • 30 Apr 2026
mRNA-4359 and pembrolizumab shows activity in advanced melanoma 2:26
mRNA-4359 and pembrolizumab shows activity in advanced melanoma
Allison Betof Warner • 30 Apr 2026
Circulating HPV DNA in surveillance and MRD-guided head & neck cancer care 1:35
Circulating HPV DNA in surveillance and MRD-guided head & neck cancer care
Ari Rosenberg • 16 Apr 2026
Liquid biopsy and ctDNA to guide treatment in head & neck cancer 4:16
Liquid biopsy and ctDNA to guide treatment in head & neck cancer
Ari Rosenberg • 16 Apr 2026
Circulating HPV DNA to guide treatment adaptation in head & neck cancer 3:03
Circulating HPV DNA to guide treatment adaptation in head & neck cancer
Ari Rosenberg • 16 Apr 2026
Phase I trial of ABBV-368 tilsotolimod, budigalimab & nab-paclitaxel in HNSCC 3:06
Phase I trial of ABBV-368 tilsotolimod, budigalimab & nab-paclitaxel in HNSCC
Ari Rosenberg • 16 Apr 2026
HPV head and neck cancer subtypes guide radiation and novel therapies 1:20
HPV head and neck cancer subtypes guide radiation and novel therapies
Wendell Yarbrough • 27 Apr 2026
The future of anti-CCR8 antibodies in solid tumor oncology 1:22
The future of anti-CCR8 antibodies in solid tumor oncology
Bruno Bockorny • 16 Apr 2026
Phase I trial of denikitug, an anti-CCR8 antibody, in advanced solid tumors 3:44
Phase I trial of denikitug, an anti-CCR8 antibody, in advanced solid tumors
Bruno Bockorny • 16 Apr 2026
Elisrasib shows durable activity in pretreated KRAS G12C-mutant NSCLC 3:30
Elisrasib shows durable activity in pretreated KRAS G12C-mutant NSCLC
Byoung Chul Cho • 27 Apr 2026
Checkpoint irAEs: immune cell origins and treatment strategies 4:09
Checkpoint irAEs: immune cell origins and treatment strategies
Kristen Pauken • 15 Apr 2026
Challenges & emerging therapies in HPV-independent head & neck cancer 6:33
Challenges & emerging therapies in HPV-independent head & neck cancer
Barbara Burtness • 15 Apr 2026
Current and upcoming clinical biomarkers for head and neck cancer 3:00
Current and upcoming clinical biomarkers for head and neck cancer
Barbara Burtness • 15 Apr 2026
PLN-101095 shows promise in immune checkpoint inhibitor-resistant tumors 6:18
PLN-101095 shows promise in immune checkpoint inhibitor-resistant tumors
Timothy Yap • 10 Apr 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals